13 May,2021 05:54 PM IST | New Delhi | PTI
Photo for representational purpose
The government has accepted the Covid-19 Working Group's recommendation for extending the gap between the two doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks, the Union health ministry said, while announcing the extension on Thursday.
Initially, the Drug Controller General of India (DGCI) had permitted the second dose of Covishield to be administered 4-6 weeks after the first, and Covaxin's second dose was supposed to be given 28 days after the first. Subsequently, this interval was extended to 4-8 weeks for Covishield and 4-6 weeks for Covaxin. In April, Centre advised that the second Covishield dose could be taken 6-8 weeks after the first. No change for Covaxin's gap for second dose has been suggested since.
"Based on the available real-life evidences, particularly from the UK, the Covid-19 Working Group agreed for increasing the dosing interval to 12-16 weeks between two doses of Covishield vaccine. No change in interval of Covaxin vaccine doses was recommended," the ministry said.
ALSO READ
‘Misguided, forced to take Covid vaccines’
Demand for compensation for injuries, deaths allegedly caused by Covid vaccines
Trump chooses anti-vaccine activist Robert F. Kennedy Jr. as health secretary
Trump expected to choose vaccine skeptic Robert F. Kennedy Jr. as health secretary: AP sources
PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen
"The recommendation of the Covid-19 Working Group was accepted by the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), headed by Dr V K Paul, Member (Health), Niti Aayog, in its meeting on May 12, 2021," the ministry said.
It has accepted this recommendation of the Covid-19 Working Group of extension of the gap between the first and second doses of Covishield to 12-16 weeks, the health ministry added.
The Covid-19 Working Group is chaired by Dr N K Arora, who is director at the INCLEN Trust.
Its members comprise Dr Rakesh Agarwal, Director and Dean, GIPMER, Puducherry; Dr Gagandeep Kang, professor, Christian Medical College, Vellore; Dr J P Mulliyal, former professor, Christian Medical College, Vellore; Dr Naveen Khanna, Group Leader, International Centre For Genetic Engineering And Biotechnology (ICGEB), JNU, New Delhi; Dr Amulya Panda, Director, National Institute of Immunology, New Delhi; and Dr V G Somani, Drugs Controller General of India (DCGI).
(with inputs from mid-day online correspondent)
